Erbitux

Icahn Accuses Bristol Of Being Underhanded

2 Comments

By Ed Silverman // August 4th, 2008 // 11:20 am

Bristol-Myers: A More Attractive Target Now?

Make a comment

By Ed Silverman // July 31st, 2008 // 7:06 pm

Bristol-Myers Offers $4.5B For ImClone Systems

6 Comments

By Ed Silverman // July 31st, 2008 // 8:45 am

Genetic Research: Opportunities & Conundrums

2 Comments

By Ed Silverman // June 2nd, 2008 // 7:36 am

Pharmalot… Pharmalittle… Good Morning

Make a comment

By Ed Silverman // June 2nd, 2008 // 6:49 am

Erbitux Prolongs Life In Lung Cancer Study

3 Comments

By Ed Silverman // May 31st, 2008 // 11:58 am

Lung Cancer Will Be A Big Focus At ASCO

Make a comment

By Ed Silverman // May 29th, 2008 // 4:28 pm

Bristol-Myers Blinks Over Erbitux Price In Canada

Make a comment

By Ed Silverman // April 28th, 2008 // 8:17 am

Genentech Faces Threat From New Erbitux Data

1 Comment

By Ed Silverman // April 21st, 2008 // 7:27 am

Pharmalot… Pharmalittle… Good Morning

Make a comment

By Ed Silverman // March 13th, 2008 // 7:28 am

Older posts »

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/